High-Dose Amoxicillin-Clavulanate Dosing for a 41 kg Child
For a 41 kg child requiring high-dose amoxicillin-clavulanate, administer 1,845 mg of amoxicillin (with 131 mg clavulanate) twice daily, which equals approximately 23 mL of the 600 mg/5 mL suspension (Augmentin ES-600) per dose. 1
Weight-Based Calculation
- The high-dose regimen is 90 mg/kg/day of amoxicillin with 6.4 mg/kg/day of clavulanate, divided into 2 doses 1, 2
- For a 41 kg child: 90 mg/kg/day × 41 kg = 3,690 mg total daily amoxicillin dose 1
- This equals 1,845 mg per dose given every 12 hours 1
- Clavulanate dose: 6.4 mg/kg/day × 41 kg = 262 mg daily (131 mg per dose) 1
Important Dosing Threshold
- Pediatric patients weighing ≥40 kg should be dosed according to adult recommendations, which means using adult tablet formulations rather than pediatric suspensions 3
- The maximum adult dose is 875 mg amoxicillin/125 mg clavulanate every 12 hours for severe respiratory infections 3
- However, for this 41 kg child requiring high-dose therapy (90 mg/kg/day), the calculated dose of 1,845 mg twice daily exceeds the standard adult maximum 1, 3
Practical Administration Options
Option 1 (Preferred for exact dosing):
- Use two 875/125 mg tablets twice daily (1,750 mg amoxicillin per dose), which approximates the calculated 1,845 mg dose 3
- This provides 3,500 mg amoxicillin daily, slightly below the calculated 3,690 mg but within therapeutic range 1
Option 2 (If suspension preferred):
- Use the 600 mg/5 mL high-dose suspension (14:1 ratio) at approximately 15 mL twice daily 1, 4
- This formulation specifically provides the 14:1 amoxicillin-to-clavulanate ratio needed for high-dose therapy 1, 4
Clinical Context for High-Dose Therapy
High-dose amoxicillin-clavulanate is indicated when any of these risk factors are present: 1
- Age <2 years
- Daycare attendance
- Recent antibiotic use (within 30 days)
- Incomplete Haemophilus influenzae type b vaccination
- Geographic area with high penicillin-resistant S. pneumoniae prevalence (>10%)
- Severe illness presentation
- Treatment failure after 48-72 hours on standard-dose amoxicillin
Pharmacokinetic Rationale
- High-dose amoxicillin (80-90 mg/kg/day) achieves middle ear fluid concentrations that exceed the MIC for intermediately resistant S. pneumoniae (penicillin MIC 0.12-1.0 µg/mL) and many highly resistant serotypes (MIC ≥2 µg/mL) 1, 5
- The 14:1 ratio formulation causes less diarrhea than other amoxicillin-clavulanate preparations while maintaining efficacy 1
- Serum amoxicillin levels increase linearly with dose, and the difference in adverse effects between lower and higher doses is generally negligible 2
Treatment Duration and Monitoring
- Continue treatment for 10 days for most respiratory tract infections including acute otitis media, pneumonia, and acute bacterial rhinosinusitis 1
- Clinical improvement should be evident within 48-72 hours; if no improvement or worsening occurs, reassess the diagnosis and consider switching to intramuscular ceftriaxone 1, 6
Critical Pitfall to Avoid
- Do not substitute two 250/125 mg tablets for one 500/125 mg tablet, as both contain the same amount of clavulanate (125 mg), resulting in excessive clavulanate dosing 3
- Do not use the 250/62.5 mg chewable tablets for children ≥40 kg, as the amoxicillin-to-clavulanate ratio is incorrect for high-dose therapy 3
- Verify the suspension concentration before dispensing to avoid dosing errors 1